PA
PRTK

Perceptive Advisors’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Perceptive Advisors’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-21,186
Closed -$532K – 153
2017
Q3 		$532K Buy
+21,186
New +$532K 0.02% 119